Article Information
- Received March 8, 2000
- Revision received April 24, 2000
- Accepted May 1, 2000
- First published July 15, 2000.
- Version of record published July 15, 2000.
Author Information
Author contributions
Disclosures
- Received March 8, 2000.
- Revision received April 24, 2000.
- Accepted May 1, 2000.
This work was supported by National Institutes of Health Grant NS16107 to S.A.S. We thank Drs. S. M. Cahoon-Metzger, M. L. Condic, and M. S. Rao for helpful comments on this manuscript. We also thank Dr. F. B. Lefcort for her generous gift of trk antibodies. Antibodies 3A10 (developed by Drs. T. M. Jessell and J. Dodd) and QCPN (developed by Drs. B. and J. Carlson) were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.
Correspondence should be addressed to Dr. Sheryl A. Scott, Department of Neurobiology and Anatomy, University of Utah School of Medicine, 50 North Medical Drive, Salt Lake City, UT 84132. E-mail:sheryl.scott{at}hsc.utah.edu.
Online Impact